SCHEMBL22172149

SCHEMBL22172149

CC(C)n1c(C(F)(F)F)nc2c(F)cc(-c3nc(Cl)ncc3F)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.47
CDK6 Q00534 17/20 0.47
CCND3 P30281 13/20 0.47
CCND1 P24385 12/20 0.47
CDK2 P24941 7/20 0.42
CDK1 P06493 5/20 0.41
CCNB1 P14635 3/20 0.41
CCNA2 P20248 2/20 0.41
KDR P35968 2/20 0.41
CDK7 P50613 3/20 0.40
CDK9 P50750 3/20 0.40
CCNE1 P24864 2/20 0.39
CIT O14578 1/20 0.39
GAK O14976 1/20 0.39
DYRK3 O43781 1/20 0.39
CCNT1 O60563 1/20 0.39
STK16 O75716 1/20 0.39
CCNK O75909 1/20 0.39
STK10 O94804 1/20 0.39
PRKD3 O94806 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29669654 0.85 CDK4 (0.55) CDK4CDK6CCND3CCND1CDK2
SCHEMBL2514899 0.85 CDK4 (0.55) CDK4CDK6CCND3CCND1CDK2
SCHEMBL22163943 0.83 CDK4 (0.40) CDK4CDK6CCND3CCND1CDK1
SCHEMBL26454120 0.82 CDK4 (0.43) CDK4CDK6CCND3CCND1CDK2
SCHEMBL21522677 0.81 CDK4 (0.61) CDK4CDK6CCND3CCND1
SCHEMBL29412424 0.81 CDK4 (0.61) CDK4CDK6CCND3CCND1
SCHEMBL29939081 0.81 CDK4 (0.41) CDK4CDK6CCND3CCND1CDK2
SCHEMBL22172140 0.80 EGFR (0.46) CDK4CDK6CCND3CCND1CDK2
SCHEMBL30309496 0.80 EGFR (0.46) CDK4CDK6CCND3CCND1CDK2
SCHEMBL19966497 0.78 CDK4 (0.38) CDK4CDK6CCND3CCND1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020135507-A1 POLYSUBSTITUTED ANILINOPYRIMIDINE DERIVATIVE AND PREPARATION METHOD AND APPLICATION THEREOF 杭州百新生物医药科技有限公司 2020-07-02 WO disclosed